RecruitingPhase 3NCT07185009
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Sponsor: Sanofi
Kingwood, TX · Lubbock, TX · San Antonio, TX · +34 more sites
Ulcerative Colitis clinical trials in Southlake, TX
10 recruiting ulcerative colitis studies with a site in Southlake, TX.
RecruitingPhase 2NCT07697456
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
Sponsor: AbbVie
Bellaire, TX · Fort Worth, TX · Garland, TX · +57 more sites
RecruitingPhase 2NCT07012395
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
Sponsor: Spyre Therapeutics, Inc.
Cedar Park, TX · Garland, TX · San Antonio, TX · +23 more sites
RecruitingPhase 3NCT06651281
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
Sponsor: Merck Sharp & Dohme LLC
Garland, TX · Lubbock, TX · +9 more sites
RecruitingPhase 2NCT07845487
A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
Sponsor: Palisade Bio
Garland, TX · Georgetown, TX · Houston, TX · +27 more sites
RecruitingPhase 3NCT07196748
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
Sponsor: Janssen Research & Development, LLC
Austin, TX · Carrollton, TX · Houston, TX · +53 more sites
RecruitingPhase 4NCT06095128
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
Sponsor: Takeda
Dallas, TX · Houston, TX · Mansfield, TX · +34 more sites
RecruitingPhase 3NCT07184996
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Sponsor: Sanofi
Baytown, TX · Dallas, TX · Harlingen, TX · +115 more sites
RecruitingPhase not listedNCT06398626
An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
Sponsor: Pfizer
Houston, TX · San Antonio, TX · +25 more sites
RecruitingPhase 2NCT07113522
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
Sponsor: Mirador Therapeutics, Inc.
Dallas, TX · Garland, TX · Georgetown, TX · +43 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.